[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2019)]

Wien Klin Wochenschr. 2019 May;131(Suppl 1):136-138. doi: 10.1007/s00508-019-1444-2.
[Article in German]


Hyper- and dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy to lower LDL cholesterol has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.

Keywords: Diabetes mellitus; Hyperlipidemia; Statins.

Publication types

  • Review

MeSH terms

  • Austria
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology
  • Comorbidity
  • Diabetes Complications / drug therapy*
  • Dyslipidemias* / drug therapy
  • Dyslipidemias* / epidemiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Hypolipidemic Agents / therapeutic use*
  • Lipids
  • Practice Guidelines as Topic
  • Risk Factors


  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Lipids